13.06.2024 - LEXINGTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) - Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the company will participate in fireside chats at the TD .
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) and Jasper Therapeutics (NASDAQ:JSPR – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, earnings and analyst recommendations. Profitability This table compares Neurocrine Biosciences and Jasper […]
Voyager Therapeutics (NASDAQ:VYGR – Free Report) had its target price reduced by Wedbush from $10.00 to $8.00 in a research note issued to investors on Tuesday morning, Benzinga reports. They currently have a neutral rating on the stock. Wedbush also issued estimates for Voyager Therapeutics’ Q2 2024 earnings at ($0.46) EPS, Q3 2024 earnings at […]
NO-BOundaries Voyager 1 E-Bike Launched on Indiegogo openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.
Voyager Therapeutics (NASDAQ:VYGR) Rating Reiterated by HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.